Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia.

作者: Silvia S. Pierangeli , Guillermina Girardi , Mariano Vega-Ostertag , Xiaowei Liu , Ricardo G. Espinola

DOI: 10.1002/ART.21157

关键词:

摘要: Objective Antiphospholipid antibodies (aPL) have been shown to induce thrombosis, activate endothelial cells, and fetal loss. The pathogenesis of aPL-induced although not completely understood, may involve platelet cell activation as well procoagulant effects aPL directly on clotting pathway components. Recent studies that uncontrolled complement leads death in aPL-treated mice. In this study, we tested the hypothesis are responsible for complement, thus generating split products thrombosis. Methods To study thrombus dynamics adhesion leukocytes used vivo murine models thrombosis microcirculation, which injections were used. Results Mice deficient components C3 C5 resistant enhanced was induced by aPL. Furthermore, inhibition using anti-C5 monoclonal prevented thrombophilia aPL. Conclusion These data show mediates 2 important effectors aPL, induction cells.

参考文章(21)
Silva S Pierangeli, Xiao Wei Liu, John H Barker, Gary Anderson, E Nigel Harris, Induction of Thrombosis in a Mouse Model by IgG, IgM and IgA Immunoglobulins from Patients with the Antiphospholipid Syndrome Thrombosis and Haemostasis. ,vol. 74, pp. 1361- 1367 ,(1995) , 10.1055/S-0038-1649940
Yi Wang, Jane Kristan, Liming Hao, Catherine S. Lenkoski, Yamin Shen, Louis A. Matis, A Role for Complement in Antibody-Mediated Inflammation: C5-Deficient DBA/1 Mice Are Resistant to Collagen-Induced Arthritis Journal of Immunology. ,vol. 164, pp. 4340- 4347 ,(2000) , 10.4049/JIMMUNOL.164.8.4340
Rick A Wetsel, Structure, function and cellular expression of complement anaphylatoxin receptors. Current Opinion in Immunology. ,vol. 7, pp. 48- 53 ,(1995) , 10.1016/0952-7915(95)80028-X
Silvia S. Pierangeli, Margaret Colden-Stanfield, Xiaowei Liu, John H. Barker, Gary L. Anderson, E. Nigel Harris, Antiphospholipid Antibodies From Antiphospholipid Syndrome Patients Activate Endothelial Cells In Vitro and In Vivo Circulation. ,vol. 99, pp. 1997- 2002 ,(1999) , 10.1161/01.CIR.99.15.1997
Milosz Jankowski, Ingrid Vreys, Christine Wittevrongel, Doris Boon, Jos Vermylen, Marc. F. Hoylaerts, Jef Arnout, Thrombogenicity of β2-glycoprotein I–dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster Blood. ,vol. 101, pp. 157- 162 ,(2003) , 10.1182/BLOOD-2002-05-1310
Yvonne Frei, John D. Lambris, Brigitta Stockinger, Generation of a monoclonal antibody to mouse C5 application in an ELISA assay for detection of anti-CS antibodies Molecular and Cellular Probes. ,vol. 1, pp. 141- 149 ,(1987) , 10.1016/0890-8508(87)90022-3
D. Ware Branch, Donald J. Dudley, Murray D. Mitchell, Kathryn A. Creighton, Thomas M. Abbott, Elizabeth H. Hammond, Raymond A. Daynes, Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. American Journal of Obstetrics and Gynecology. ,vol. 163, pp. 210- 216 ,(1990) , 10.1016/S0002-9378(11)90700-5
C. Kondo, M. Mizuno, K. Nishikawa, Y. Yuzawa, N. Hotta, S. Matsuo, The role of C5a in the development of thrombotic glomerulonephritis in rats Clinical and Experimental Immunology. ,vol. 124, pp. 323- 329 ,(2001) , 10.1046/J.1365-2249.2001.01513.X
Guillermina Girardi, Patricia Redecha, Jane E Salmon, Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation Nature Medicine. ,vol. 10, pp. 1222- 1226 ,(2004) , 10.1038/NM1121
Antonella Circolo, Gérard Garnier, Wataru Fukuda, Xeufeng Wang, Tünde Hidvegi, Alexander J Szalai, David E Briles, John E Volanakis, Rick A Wetsel, Harvey R Colten, Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA Immunopharmacology. ,vol. 42, pp. 135- 149 ,(1999) , 10.1016/S0162-3109(99)00021-1